tiprankstipranks
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
US Market

Compare Upstream Bio, Inc. (UPB) vs. Competitors

261 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Upstream Bio, Inc.
$30.30
$567.06M
-10.19
59.57%
6 Buy
1 Hold
0 Sell
Strong Buy
Theravance Biopharma
$16.55
$852.21M
3.90
94.02%
3 Buy
3 Hold
0 Sell
Moderate Buy
Bicycle Therapeutics
$4.97
$344.76M
-2.24
-27.76%
4 Buy
3 Hold
0 Sell
Moderate Buy
Prime Medicine, Inc.
$3.51
$633.74M
-2.57
180.80%
4 Buy
1 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$21.98
$1.44B
-6.67
111.35%
8 Buy
2 Hold
0 Sell
Strong Buy
Zenas BioPharma, Inc.
$21.28
$1.22B
184.11%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
UPB
Upstream Bio, Inc.
10.42
4.02
62.81%
TBPH
Theravance Biopharma
16.55
8.16
97.26%
BCYC
Bicycle Therapeutics
4.97
-1.56
-23.89%
PRME
Prime Medicine, Inc.
3.51
2.34
200.00%
BCAX
Bicara Therapeutics Inc.
21.98
11.83
116.55%
ZBIO
Zenas BioPharma, Inc.
21.28
14.50
213.86%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts